Dexamethasone Palmitate for PONV After Open Surgery

NARecruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

December 31, 2026

Conditions
Postoperative Nausea and VomitingDexamethasone PalmitateOpen Surgery
Interventions
DRUG

Dexamethasone Palmitate

Patients in the dexamethasone palmitate group will be assigned to receive intravenous injection of dexamethasone palmitate 8 mg (contains 5mg dexamethasone) after anesthesia induction and before surgical incision.

DRUG

Dexamethasone

Patients in the dexamethasone group will be assigned to receive intravenous injections of dexamethasone 5 mg after anesthesia induction and before surgical incision.

Trial Locations (1)

100050

RECRUITING

Fang Luo, Beijing

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER

NCT06997419 - Dexamethasone Palmitate for PONV After Open Surgery | Biotech Hunter | Biotech Hunter